The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label phase Ib study of entinostat (E), and lapatinib (L) alone, and in combination with trastuzumab (T) in patients (pts) with HER2+ metastatic (mHER2+) breast cancer after progression on trastuzumab.
 
Bora Lim
No Relationships to Disclose
 
Rashmi Krishna Murthy
No Relationships to Disclose
 
Summer Jackson
No Relationships to Disclose
 
Jie S. Willey
No Relationships to Disclose
 
Jangsoon Lee
No Relationships to Disclose
 
Ricardo H. Alvarez
No Relationships to Disclose
 
Carlos Hernando Barcenas
No Relationships to Disclose
 
Meghan Sri Karuturi
No Relationships to Disclose
 
Nuhad K. Ibrahim
Honoraria - Celgene; Novartis; Roche
Speakers' Bureau - Celgene; Novartis; Roche
Research Funding - Archer (Inst); GenomeDx (Inst); Newlink Genetics (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Daniel J. Booser
No Relationships to Disclose
 
Stacy L. Moulder
Research Funding - Bayer (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Novartis
 
Sharon Hermes Giordano
No Relationships to Disclose
 
Abenaa M. Brewster
No Relationships to Disclose
 
Ronald Stewart Walters
No Relationships to Disclose
 
Powel Brown
No Relationships to Disclose
 
Debu Tripathy
Consulting or Advisory Role - Merck; Nektar; Novartis; Oncoplex Diagnostics; Pfizer
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Novartis
 
Vicente Valero
No Relationships to Disclose
 
Naoto T. Ueno
No Relationships to Disclose